11
TITLE: Effectiveness and Safety of Rivaroxaban Compared to Acenocumarol after Infrainguinal Surgical Revascularization
AUTHORS: Vitor Ferreira; Cristiana Freixo; Joao Goncalves; Gabriela Teixeira; Ines Antunes; Carlos Veiga; Daniel Mendes; Joana Martins; Rui Almeida;
PUBLISHED: 2019, SOURCE: ANNALS OF VASCULAR SURGERY, VOLUME: 55
INDEXED IN: Scopus WOS
13
TITLE: SB5 and reference adalimumab show cross-immunogenicity in patients with inflammatory bowel disease or rheumatoid arthritis  Full Text
AUTHORS: Goncalves, J; Myung, G; Hong, E; Park, M; Jeong, D; Ghil, J;
PUBLISHED: 2019, SOURCE: JOURNAL OF CROHNS & COLITIS, VOLUME: 13
INDEXED IN: WOS
14
TITLE: Foreword
AUTHORS: Cláudio, AP; Bouatouch, K; Braz, J;
PUBLISHED: 2019, SOURCE: 14th International Conference on Computer Graphics Theory and Applications, GRAPP 2019 - Part of the 14th International Joint Conference on Computer Vision, Imaging and Computer Graphics Theory and Applications, VISIGRAPP 2019 in VISIGRAPP 2019 - Proceedings of the 14th International Joint Conference on Computer Vision, Imaging and Computer Graphics Theory and Applications, VOLUME: 1
INDEXED IN: Scopus
15
TITLE: Biosimilars: An Opportunity to Update the Product Information of Biological Drugs Regarding their Immunogenicity  Full Text
AUTHORS: Rodrigo Borrega; Joao Paulo Cruz; Peter Taylor; Joao Goncalves;
PUBLISHED: 2019, SOURCE: BIODRUGS, VOLUME: 33, ISSUE: 6
INDEXED IN: Scopus WOS
16
TITLE: Analysis of Immunogenicity Data in the Product Information of Biological Drugs: A Need to Report Immunogenicity Data Systematically
AUTHORS: Rodrigo Borrega; Joao Paulo Cruz; Peter Taylor; Joao Goncalves;
PUBLISHED: 2019, SOURCE: BIODRUGS, VOLUME: 33, ISSUE: 6
INDEXED IN: Scopus WOS
17
TITLE: Synthetic cathinones: an evolving class of new psychoactive substances  Full Text
AUTHORS: Joao L Goncalves; Vera L Alves; Joselin Aguiar; Helena M Teixeira; Jose S Camara ;
PUBLISHED: 2019, SOURCE: CRITICAL REVIEWS IN TOXICOLOGY, VOLUME: 49, ISSUE: 7
INDEXED IN: WOS
18
TITLE: Antigenic response to CT-P13 and remicade in inflammatory bowel disease patients shows similar epitope recognition  Full Text
AUTHORS: Goncalves, J; Santos, M; Acurcio, R; Iria, I; Gouveia, L; Brito, P; Cunha C C Santos; Barbas, A; Galvao, J; Barbosa, I; Aires A da Silva; Alcobia, A; Cavaco, M; Cardoso, M; Delgado D Alves; Carey, J; Dorner, T; Eurico E Fonseca; Palmela, C; Torres, J; Lima L Vieira; Trabuco, D; Fiorino, G; Strik, A; Yavzori, M; Rosa, I; Correia, L; Magro, F; D'Haens, G; Ben Horin, S; Lakatos, P; Danese, S; ...More
PUBLISHED: 2018, SOURCE: JOURNAL OF CROHNS & COLITIS, VOLUME: 12
INDEXED IN: WOS
19
TITLE: Editorial: antigenic response to CT-P13 and infliximab originator in IBD shows similar epitope recognition-evidence from basic science supports safe switching to biosimilars. Authors' reply  Full Text
AUTHORS: Goncalves, J; Magro, F ; Danese, S; Lakatos, PL; Ben Horin, S;
PUBLISHED: 2018, SOURCE: ALIMENTARY PHARMACOLOGY & THERAPEUTICS, VOLUME: 48, ISSUE: 5
INDEXED IN: Scopus WOS CrossRef
20
TITLE: IMMUNOGENICITY OF BIOSIMILARS FOR RHEUMATIC DISEASES: AN UPDATED REVIEW FROM REGULATORY DOCUMENTS AND CONFIRMATORY CLINICAL TRIALS
AUTHORS: Strand, V; Goncalves, J; Hickling, TP; Jones, H; Marshall, L; Isaacs, J;
PUBLISHED: 2018, SOURCE: Congress of the European-League-Against-Rheumatism (EULAR) in ANNALS OF THE RHEUMATIC DISEASES, VOLUME: 77
INDEXED IN: WOS
Page 2 of 10. Total results: 100.